146 related articles for article (PubMed ID: 24942315)
1. Enzymes in the dissolution testing of gelatin capsules.
Marques MR
AAPS PharmSciTech; 2014 Dec; 15(6):1410-6. PubMed ID: 24942315
[TBL] [Abstract][Full Text] [Related]
2. Influence of enzymes and surfactants on the disintegration behavior of cross-linked hard gelatin capsules during dissolution.
Pennings FH; Kwee BL; Vromans H
Drug Dev Ind Pharm; 2006 Jan; 32(1):33-7. PubMed ID: 16455602
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance.
Digenis GA; Gold TB; Shah VP
J Pharm Sci; 1994 Jul; 83(7):915-21. PubMed ID: 7965669
[TBL] [Abstract][Full Text] [Related]
4. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
Wu Y; Zhao F; Paborji M
Pharm Dev Technol; 2003; 8(4):379-83. PubMed ID: 14601962
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.
Marchais H; Cayzeele G; Legendre JY; Skiba M; Arnaud P
Eur J Pharm Sci; 2003 Jun; 19(2-3):129-32. PubMed ID: 12791415
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
Likar MD; Carroll SC; Colgan ST; Yeoh T; MacDonald BC; Johnson GM; Space JS
J Pharm Sci; 2018 Dec; 107(12):3080-3088. PubMed ID: 30145210
[TBL] [Abstract][Full Text] [Related]
7. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
Strauch S; Jantratid E; Dressman JB
J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
[TBL] [Abstract][Full Text] [Related]
8. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
Lu X; Xiao B; Lo L; Bolgar MS; Lloyd DK
J Pharm Biomed Anal; 2011 Aug; 56(1):23-9. PubMed ID: 21620602
[TBL] [Abstract][Full Text] [Related]
9. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
Ofner CM; Zhang YE; Jobeck VC; Bowman BJ
J Pharm Sci; 2001 Jan; 90(1):79-88. PubMed ID: 11064381
[TBL] [Abstract][Full Text] [Related]
10. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
Al-Tabakha MM; Arida AI; Fahelelbom KM; Sadek B; Saeed DA; Abu Jarad RA; Jawadi J
Drug Dev Ind Pharm; 2015; 41(10):1726-37. PubMed ID: 25586554
[TBL] [Abstract][Full Text] [Related]
11. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
Sherry Ku M; Li W; Dulin W; Donahue F; Cade D; Benameur H; Hutchison K
Int J Pharm; 2010 Feb; 386(1-2):30-41. PubMed ID: 19900518
[TBL] [Abstract][Full Text] [Related]
12. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
Adesunloye TA; Stach PE
Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
[TBL] [Abstract][Full Text] [Related]
13. The shell dissolution of various empty hard capsules.
Chiwele I; Jones BE; Podczeck F
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):951-6. PubMed ID: 10923822
[TBL] [Abstract][Full Text] [Related]
14. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaradehyde.
Yong CS; Li DX; Oh DH; Kim JA; Yoo BK; Woo JS; Rhee JD; Choi HG
Arch Pharm Res; 2006 Jun; 29(6):520-4. PubMed ID: 16833022
[TBL] [Abstract][Full Text] [Related]
15. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules.
Meyer MC; Straughn AB; Mhatre RM; Hussain A; Shah VP; Bottom CB; Cole ET; Lesko LL; Mallinowski H; Williams RL
Pharm Res; 2000 Aug; 17(8):962-6. PubMed ID: 11028942
[TBL] [Abstract][Full Text] [Related]
16. Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus.
Garbacz G; Cadé D; Benameur H; Weitschies W
Eur J Pharm Sci; 2014 Jun; 57():264-72. PubMed ID: 24021609
[TBL] [Abstract][Full Text] [Related]
17. Soft gelatin capsules. I. Factors affecting capsule shell dissolution rate.
Hom FS; Veresh SA; Miskel JJ
J Pharm Sci; 1973 Jun; 62(6):1001-6. PubMed ID: 4576423
[No Abstract] [Full Text] [Related]
18. Studies on the influence of pH and pancreatin on 13C-formaldehyde-induced gelatin cross-links using nuclear magnetic resonance.
Gold TB; Smith SL; Digenis GA
Pharm Dev Technol; 1996 Apr; 1(1):21-6. PubMed ID: 9552327
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
Liu JP; Ma X; Zhu JB
Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
[TBL] [Abstract][Full Text] [Related]
20. Effect of Four Commonly Used Dissolution Media Surfactants on Pancreatin Proteolytic Activity.
Guncheva M; Stippler E
AAPS PharmSciTech; 2017 May; 18(4):1402-1407. PubMed ID: 27586964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]